Nyrada Inc. (ASX:NYR)
Australia · Delayed Price · Currency is AUD 0.5000
-0.0150 (-2.91%)
May 29, 2026, 4:10 PM AEST
Nyrada Market Cap
Nyrada has a market cap or net worth of 122.47 million as of May 29, 2026. Its market cap has increased by 453.03% in one year.
Market Cap
122.47M
Enterprise Value
115.35M
Revenue
2.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.50
Market Cap Chart
Since January 16, 2020, Nyrada's market cap has increased from 25.71M to 122.47M, an increase of 376.46%. That is a compound annual growth rate of 27.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 122.47M | -55.05% |
| Dec 31, 2025 | 272.45M | 1,278.00% |
| Dec 31, 2024 | 19.77M | 476.06% |
| Dec 29, 2023 | 3.43M | -84.83% |
| Dec 30, 2022 | 22.62M | -39.58% |
| Dec 31, 2021 | 37.44M | 42.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orthocell | 208.27M |
| Recce Pharmaceuticals | 159.05M |
| Actinogen Medical | 136.47M |
| Island Pharmaceuticals | 112.45M |
| Dimerix | 111.07M |
| Alterity Therapeutics | 97.88M |
| Paradigm Biopharmaceuticals | 86.70M |
| Arovella Therapeutics | 85.82M |